"
Team:SupBiotech-Paris
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 2: | Line 2: | ||
| - | + | ||
| - | + | ==Team SupBiotech-Paris== | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | Team SupBiotech-Paris | + | |
| - | + | ||
<br> | <br> | ||
<font color="#002bb8"> | <font color="#002bb8"> | ||
Revision as of 22:28, 18 August 2009
Project
Introduction Current therapies Gene therapies DVS Concept Tissue Vector Cell Vector Therapeutic plasmid Conclusion Implementation Tissue targeting Antitumor action Treatment modeling Conclusion
Ressources
BioBricks Material & Method Bibliography
Ethics & Safety
Team SupBiotech-Paris
Welcome Foreigner,
Our project is a vectorization system, we chose mycobacterium, a microorganism with high tropism for specific tissues, and a synthetic Lambda phage able to infect eukaryotic cells.First, to target tissue, we use mycobacterium, and then to target the cell population, we use the synthetic lambda phage.
See you guys!
